<5838> Rakuten Bank 2869 -216

Significant decline. Today, the insurance and banking sectors are among the top decliners by industry. The yield on newly issued 10-year government bonds fell below 0.8% for the first time since August 5, which appears to have been a negative factor for financial-related stocks. BOJ Governor Ueda mentioned in a speech the previous day that the decision on future interest rate hikes should be made "timely and appropriately," emphasizing the need to "carefully confirm the trends in the financial markets and the overseas economic situation. There appears to be a sense of postponement in the timing of additional interest rate hikes.

<5384> FUJIMI 2353 +73

Significant rebound. At Iwai Cosmo Securities, the investment rating has been upgraded to 'A' with a target stock price of 2800 yen. Advanced semiconductors are increasing in importance due to miniaturization and three-dimensional structuring in the flattening process. The company, a major CMP slurry supplier, is expanding its growth opportunities. It is estimated that over 30% of sales are to TSMC, with upcoming initiatives such as starting to manufacture 2-nanometer semiconductors from next year providing additional tailwinds.

<2329> Tohoku Shinsha 651 -72

Significant drop. The discussions regarding the delisting of shares proposed by 3D Investments have been terminated. The company had previously announced on August 22 its response to the TOB and delisting proposals from 3D Investments, stating that the decision not to comply was substantial. While allowing for stringent confidentiality agreements in due diligence, expectations for TOB premiums are currently diminishing.

<4918> Ivy 318 +20

Significant increase. The company had announced an upward revision of its earnings forecast the previous day. The first-half operating profit has been raised from the previous estimate of 12 million yen to 19 million yen, while for the full year, it has been increased from 28 million yen to 45 million yen, more than doubling compared to the previous year. Sales increases of high-margin products have reduced cost rates, and the introduction of large new products is expected to have a positive effect in the second half. As the first-quarter operating loss was almost at the same level as the previous year, the substantial upward revision indicates a strong positive surprise.

<3086> J. Front 1534.5 +18

Continued increase. The upward revision of performance estimates was announced the day before. The first-half operating profit was raised from the previous forecast of 27 billion yen to 39.3 billion yen, and for the full year, it was increased from 41.5 billion yen to 52 billion yen. By recording an acquisition difference profit of approximately 8.5 billion yen in the second quarter, the revision range expands, but even at the operating profit level, there is an upward trend due to tax-exempt sales growth, etc. The annual dividend was also increased from the previous plan of 40 yen to 44 yen. The upside itself is already priced in, and the second-half operating profit is essentially a downward revision, so the positive reaction is somewhat limited.

<4516> Nichiinyaku 3866 +478

Sharply rose. J&J has announced that it has obtained manufacturing and marketing approval from the lung arterial pulmonary hypertension for the combination tablet called "Yubanshi combination tablet", which is a combination of the endothelin receptor antagonist macitentan 10mg and the phosphodiesterase 5 inhibitor tadalafil 40mg. Positive movements are ahead in response to the expansion of developments in the field of pulmonary hypertension related areas positioned as one of the focusing areas.

<4911> Shiseido 3671 +111

Significant continued increase. In China the previous day, additional monetary easing measures were announced one after another. In addition to suggesting additional interest rate cuts, support measures for real estate and the stock market were also introduced. The effects of these measures are expected to buoy the Chinese economy. In the U.S. market, there is a buy preference for China-related stocks, with Estee Lauder rising by over 6%, which is linked to the company's stimulus. Also, today Sazaby League, Yasukawa Electric, Tsugami, Nippon Paint, and other China-related stocks are widely being bought.

<6857> Advantest 6547 +232

Significantly continued increase. At SMBC Nikko Securities, the investment rating was raised from "2" to "1", and the target stock price was also raised from 5600 yen to 7900 yen. For the fiscal year ending March 2025, they exceeded the company's plan of 138 billion yen, achieving 141 billion yen, and for the fiscal year ending March 2026, they raised it from the previous 139 billion yen to 195 billion yen. In the midst of downward revisions in expectations for SPE and semiconductors, it is being analyzed as a position for escape. Attention is also drawn to the realization of AI expectations contributing to actual performance.

koss corp 1917 +163

Sharp rebound. It has been announced that Cybozu will implement the acquisition of treasury shares, up to 3 million shares representing 6.3% of the issued shares and 3 billion yen, with the acquisition period from October 1 to December 24. The purpose of the acquisition is to advance the reconstruction of capital structure and implement a flexible capital policy in response to changes in the business environment. Expectations are towards the impact on supply and demand from the high level of share buyback in a short period. Additionally, the monthly trends for August have been announced, and the continued favorable progress is set to continue.

Sugi Holdings Co., Ltd. 2569.5 +116.5

Significant rebound. The company announced its first-half results the previous day. Operating profit is 20.3 billion yen, a 17.3% increase from the same period last year. In the period from June to August, it is 11.7 billion yen, a 22.8% increase, with the growth rate expanding. It seems to exceed market expectations by just over 0.5 billion yen. The improvement in the gross profit margin for merchandise continues, covering situations such as increased sales and management expenses. The full-year plan of 40 billion yen, a 9.2% increase from the previous year, is maintained, but the likelihood of an upward revision appears to be increasing.